Nonuraemic cutaneous calciphylaxis: our experience with a challenging disease

Clin Exp Dermatol. 2020 Aug;45(6):745-746. doi: 10.1111/ced.14242. Epub 2020 May 18.

Authors

J M Neves¹, J Cabete¹, C Fernandes¹

Affiliation

¹ Department of Dermatology and Venereology, Hospital de Santo António dos Capuchos, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.

PMID: 32304580
DOI: 10.1111/ced.14242

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Intravenous
Adult
Aged
Aged, 80 and over
Alendronate / administration & dosage
Alendronate / therapeutic use
Bone Density Conservation Agents / administration & dosage
Bone Density Conservation Agents / therapeutic use
Calciphylaxis / diagnosis
Calciphylaxis / drug therapy*
Calciphylaxis / etiology
Calciphylaxis / pathology*
Diphosphonates / administration & dosage
Diphosphonates / therapeutic use
Female
Humans
Kidney Failure, Chronic / complications*
Leg Ulcer / etiology
Leg Ulcer / pathology*
Leg Ulcer / surgery
Male
Middle Aged
Outcome Assessment, Health Care
Transplants / transplantation
Zoledronic Acid / administration & dosage
Zoledronic Acid / therapeutic use

Substances

Bone Density Conservation Agents
Diphosphonates
Zoledronic Acid
Alendronate